Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Haematologica|October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHarald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.
Arthritis and Rheumatism|February 16, 2010
Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritisStephan Blüml, Nikolaus B Binder, Birgit Niederreiter, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2018
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancerFelix Harpain, Mohamed A Ahmed, Xenia Hudec, et al.
Thrombosis Research|February 1, 2012
Continuous thrombin infusion leads to a bleeding phenotype in sheepJolanta M Siller-Matula, Ingrid Miller, Manfred Gemeiner, et al.
Wiener Klinische Wochenschrift|July 21, 2010
[Tumor stem cell research - basis and challenge for diagnosis and therapy]Heidrun Karlic, Harald Herrmann, Axel Schulenburg, et al.
Blood|January 1, 2005
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotidesKarl J Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 2017
ÖGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demandsBrigitte Zurl, Anja Bayerl, Alexander De Vries, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neckFelix Keil, Edgar Selzer, Andrea Berghold, et al.
Wiener Klinische Wochenschrift|July 15, 2018
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectivesPeter Valent, Emir Hadzijusufovic, Thomas Grunt, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2014
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapyKarin Schelch, Mir A Hoda, Thomas Klikovits, et al.
Pageof 8